Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.J&J to acquire Japanese firm Ci:z for $2.04bn
Johnson & Johnson (J&J) has agreed to acquire all outstanding shares of Japanese skincare firm, Ci:z Holdings, in a deal valued at around ¥230bn ($2.04bn).
Production & Sales
-
24 Oct 2018
-
17 Oct 2018
Quotient Sciences opens early-phase formulation and manufacturing plant in US
Drug development services provider Quotient Sciences has opened a 45,000ft² manufacturing facility near Philadelphia, in Garnet Valley, Pennsylvania.
-
15 Oct 2018
Dr. Reddy’s to sell API manufacturing business unit in Hyderabad, India
Dr. Reddy’s Laboratories has agreed to divest its its API manufacturing business unit located in Jeedimetla, Hyderabad, located in the Indian state of Telangana, to generics pharmaceutical firm Therapiva Private.
-
09 Oct 2018
eTheRNA immunotherapies opens mRNA manufacturing facility in Belgium
Clinical-stage firm eTheRNA immunotherapies has opened a mRNA facility in Belgium for production of mRNA immunotherapies.
-
03 Oct 2018
Alliance Pharma launches nausea drug Xonvea in UK
Alliance Pharma has launched Xonvea, a new prescription drug for the treatment of nausea and vomiting of pregnancy (NVP), in the UK.
-
01 Oct 2018
Dr. Reddy’s Laboratories sells antibiotic manufacturing site in Bristol, Tennessee
Dr. Reddy’s Laboratories has sold its antibiotic manufacturing facility and related assets in Bristol, Tennessee to Neopharma, a wholly owned subsidiary of the UAE’s largest pharmaceutical manufacturer headquartered in Abu Dhabi.
-
01 Oct 2018
Recipharm acquires Sanofi inhalation contract manufacturing business
Recipharm has completed the purchase of Sanofi’s inhalation contract manufacturing business including a manufacturing plant situated in Holmes Chapel, UK.
-
28 Sep 2018
Dova, Salix sign exclusive co-promotion deal for Doptelet
Dova Pharmaceuticals, Salix Pharmaceuticals and its parent company Bausch Health Companies have entered into an exclusive agreement to co-promote Dova’s Doptelet (avatrombopag) in the US.
-
26 Sep 2018
Gilead to launch generic versions of hepatitis C drugs in US
Gilead Sciences is planning to launch authorized generic versions of Epclusa (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni (ledipasvir 90mg/sofosbuvir 400mg) in the US.
-
26 Sep 2018
Tris Pharma acquires Pfizer’s subsidiary NextWave Pharmaceuticals
Tris Pharma, a developer of technology-based therapeutic products, has acquired Pfizer’s subsidiary NextWave Pharmaceuticals for an undisclosed sum.